/
Transition from acute pain to chronic pain Transition from acute pain to chronic pain

Transition from acute pain to chronic pain - PowerPoint Presentation

ZestyZenMaster
ZestyZenMaster . @ZestyZenMaster
Follow
342 views
Uploaded On 2022-08-04

Transition from acute pain to chronic pain - PPT Presentation

Dr S Parthasarathy MD DA DNB MD Acu Dip Diab Dip Software based statistics PhD physiology FICA IDRA CUGRA Associate editor IJA Topic to surgical exposures only Acute pain is an unpleasant sensory and emotional experience associated with actual or potential tiss ID: 935546

chronic pain surgery cpsp pain chronic cpsp surgery surgeries damage pag simple receptor opioids potential tissue local target nociceptors

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Transition from acute pain to chronic pa..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Transition from acute pain to chronic pain

Dr. S. Parthasarathy

MD., DA., DNB, MD (

Acu

), Dip. Diab.

Dip. Software based statistics- PhD ( physiology),

FICA, IDRA , CUGRA

Associate editor IJA

Slide2

Topic to surgical exposures only !

Acute pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage

It has to heal by 12 weeks !!

Persist for 3 months !

Slide3

What is CPSP ??

International Classification of Diseases defines CPSP as pain developing or increasing in intensity after a surgical procedure, in the area of the surgery, persisting beyond the healing process (

ie

, at least 3 months) and not better explained by another cause such as infection, malignancy, or a pre-existing pain condition

Slide4

What is it actually !!

Consequence of surgery

Persists for more than 2 -3 months

No underlying disease found out

The preoperative pain should not have continued – not a continuum

Slide5

Which surgeries cause CPSP ?

Inguinal hernia – 15 % ??

Breast surgeries - 50 %

Thoracotomies - 50 %

Lower limb amputation - 70%

Sternotomy - 30%

Pelvic fracture surgeries -30%

Some say – 5 – 55%

But overall moderate pain – 10 %

Slide6

Its not simple pain !

Its not simple preoperative

pain

Increased intensity

Emotive component

Depression

Behavioural changes !!

Sometimes it happens with trauma

Its not as planned as surgery

It can happen even in children almost similar incidence

Slide7

Risk factors - CPSP

Young females

Smokers

Obesity

Medical conditions

Preoperative pain

Long surgery

Psychological vulnerability

Ineffective acute pain relief

Nerve injury

Cut nerves !!

Slide8

Pain genetics !

Pain genetics is a young, rapidly developing field.

It promises to account for trait variance in chronic pain states as well as vulnerability to developing chronic pain.

Individual differences are high in almost all chronic pain syndromes

Epigenetics is the study of heritable changes in gene expression caused by mechanisms other than changes in the underlying DNA sequence, namely DNA methylation and histone modification that bring about chromatin remodeling

Slide9

Intensive care units

Slide10

Periphery – what happens

Up-regulation of substance P,

phosphorylation of various enzymes (e.g. protein kinase A and C),

activation of transient receptor potential vanilloid (TRPV) receptor and purinergic

receptor,

increased responsiveness of the nociceptors, - retrograde neurogenic inflammation

activation of silent nociceptors.

changes potentiate nociception; leading to a state of ‘peripheral hypersensitivity’ and

hyperalgesia.

Slide11

NE

PKC

Periphery

Slide12

Central

Slide13

In the brain ?

Systemic inflammation

Adrenergic surge

Other effects

+ noradrenaline stimulates nociceptors

Functional MRI studies have demonstrated changes in the

centres

of the brain matrix of patients with chronic pain.

Slide14

Descending control – stimulate – pain ??

The PAG and the nucleus raphe magnus (NRM) emerged early on as key midbrain structures in opioid related endogenous pain modulation.

Electrical stimulation of the PAG in animals inhibits spinal nociceptive processing, and microinjection of opioids disinhibits inhibitory neurons in the PAG, accentuating descending anti-nociception

Slide15

Descending control area diseased – no hyperalgesia

Slide16

Prevention

Target the risk factors and beware

Careful tissue handling,

Prevent nerve damage

and minimal invasive surgical techniques (LAP) during surgery minimize tissue damage and potentially reduce the risk of chronic pain

Slide17

Anesthetic influence

The surge is more on DAY 1

Rigorous multimodal

Study proved that epidural local with morphine – decreased the incidence of CPSP after breast surgeries

Preemptive analgesia

Simple local infiltration prior !

Peripheral nerve blocks with long duration

Intrathecal narcotics

TAP catheters

Slide18

What's in the periphery ?

Local anesthetic infiltration

NSAIDS – role of caspase inhibition ! ( apoptosis and inflammation enzymes)

COX 2 inhibitors

Duloxetine

Glutamate modulators ?

Slide19

Continuous good post op analgesia – outcome !!

Slide20

Central prevention

Oxytocin

Alpha 2 agonists

Cannabinoids

Slide21

Target each component

Pregabalin

Gabapentin

Valproate

Slide22

Targets

Magnesium

Ketamine

Dextrometharphan

Slide23

Capsaicin

Depletes substance p

Stimulates TRPV1 –

excessive calcium influx

Disruption of nociceptive

input

Ruthenium ,

capsezepine

Slide24

Opioids

Slide25

Other options

Ruboxistaurin

– PKC inhibitors

Tanezumab - NGF inhibitors

Adenosine monophosphate-activated protein kinase (AMPK) has recently emerged as a novel target for the treatment of pain with the exciting potential for disease modification- metformin and other new drugs

Non CPSP chronic pain syndromes

Slide26

When it has come – assess all components biopsychosocial !!

Gabapentin, duloxetine ‘ziconotide

Purine antagonists

Neuro modulation – acupuncture , TENS

Slide27

Severe cases

Neural blocks

Neurolytics

Radiofrequency ablation

PAG and opioids – are they used more ?

Slide28

Slide29

Slide30

Slide31

Slide32

Summary

CPSP – what is it ? Why ?

Problem ?

When and which surgeries

Why – three targets

Chemicals and drugs

Transitional pain

centre

Thank you all